@article{TLCR282,
author = {Caicun Zhou},
title = {Multi-targeted tyrosine kinase inhibitors for the treatment of non-small cell lung cancer: an era of individualized therapy},
journal = {Translational Lung Cancer Research},
volume = {1},
number = {1},
year = {2012},
keywords = {},
abstract = {Multi-targeted tyrosine kinase inhibitors (TKIs) have played an increasingly important role in the treatment of non-small cell lung cancer (NSCLC). Many recently published phase III trials have shown bittersweet efficacies of these drugs. How to optimize the efficacies of TKIs has been a hot topic in the era of individualized therapy. In this article, we review the up-to-dated advances in research on the application of TKIs for NSCLC treatment.},
issn = {2226-4477}, url = {https://tlcr.amegroups.org/article/view/282}
}